Makers Laboratories (BOM:506919) Cyclically Adjusted Revenue per Share: ₹198.92 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506919 Makers Laboratories Ltd BOM:506919
67 GF Score
Price ₹195.75
GF Value ₹182.26
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Makers Laboratories Cyclically Adjusted Revenue per Share?

Makers Laboratories BOM:506919 -5.04% 67 Cyclically Adjusted Revenue per Share is ₹198.92 as of Jun. 2026. GuruFocus rates BOM:506919 with a GF Score™ of 67/100 and a GF Value™ of ₹182.26 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Makers Laboratories's adjusted revenue per share for the three months ended in Jun. 2026 was ₹72.507. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹198.92 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Makers Laboratories's average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Makers Laboratories was 4.60% per year. The lowest was 2.50% per year. And the median was 3.70% per year.

As of today (2026-08-31), Makers Laboratories's current stock price is ₹195.75. Makers Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹198.92. Makers Laboratories's Cyclically Adjusted PS Ratio of today is 0.98.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Makers Laboratories was 2.11. The lowest was 0.57. And the median was 0.82.


Makers Laboratories  (BOM:506919) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Makers Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=195.75/198.92
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Makers Laboratories was 2.11. The lowest was 0.57. And the median was 0.82.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Makers Laboratories Cyclically Adjusted Revenue per Share Related Terms


Makers Laboratories Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Makers Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Makers Laboratories Cyclically Adjusted Revenue per Share Chart

Makers Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 166.97 172.18 174.48 179.57 192.05

Makers Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 182.57 186.18 189.36 192.05 198.92

BOM:506919 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Makers Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Makers Laboratories Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Makers Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Makers Laboratories's Cyclically Adjusted PS Ratio falls into.


BOM:506919
67GF Score
Makers Laboratories Ltd BOM:506919
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Makers Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Makers Laboratories's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=72.507/167.3573*167.3573
=72.507

Current CPI (Jun. 2026) = 167.3573.

Makers Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 35.905 105.961 56.709
201612 25.841 105.196 41.111
201703 28.108 105.196 44.717
201706 22.039 107.109 34.436
201709 33.630 109.021 51.625
201712 27.504 109.404 42.073
201803 26.313 109.786 40.111
201806 27.729 111.317 41.689
201809 27.998 115.142 40.695
201812 19.907 115.142 28.935
201903 15.522 118.202 21.977
201906 20.023 120.880 27.722
201909 33.659 123.175 45.732
201912 21.696 126.235 28.764
202003 24.289 124.705 32.596
202006 16.860 127.000 22.218
202009 26.742 130.118 34.395
202012 29.073 130.889 37.173
202103 70.971 131.771 90.138
202106 70.729 134.084 88.280
202109 65.409 135.847 80.581
202112 57.441 138.161 69.580
202203 53.191 138.822 64.125
202206 44.380 142.347 52.177
202209 41.132 144.661 47.585
202212 32.858 145.763 37.726
202303 47.507 146.865 54.136
202306 42.324 150.280 47.134
202309 42.519 151.492 46.972
202312 44.848 152.924 49.081
202403 46.027 153.035 50.335
202406 50.189 155.789 53.916
202409 50.098 157.882 53.105
202412 46.662 158.323 49.325
202503 59.867 157.552 63.593
202506 59.314 159.755 62.137
202509 58.669 162.289 60.501
202512 60.484 163.281 61.994
202603 60.483 164.272 61.619
202606 72.507 167.357 72.507

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹198.92 mean?
Makers Laboratories (BOM:506919) has a Cyclically Adjusted Revenue per Share of ₹198.92 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Makers Laboratories and its competitors.
Is Makers Laboratories' Cyclically Adjusted Revenue per Share too high?
Makers Laboratories' current Cyclically Adjusted Revenue per Share is ₹198.92. Overall, Makers Laboratories has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Makers Laboratories' Cyclically Adjusted Revenue per Share compare to ZTS?
Makers Laboratories' Cyclically Adjusted Revenue per Share of ₹198.92 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Makers Laboratories and its competitors. Makers Laboratories's current Cyclically Adjusted Revenue per Share is ₹198.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Makers Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Makers Laboratories (BOM:506919) is currently considered Fairly Valued. The stock's GF Value™ is ₹182.26, compared to a current price of ₹195.75 — trading 7.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹198.92. Makers Laboratories' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Makers Laboratories (BOM:506919), the current Cyclically Adjusted Revenue per Share is ₹198.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Makers Laboratories (BOM:506919) Overvalued in 2026?

Based on GuruFocus' analysis, Makers Laboratories stock appears to be overvalued. The current stock price of ₹195.75 is trading 7.4% above its estimated GF Value™ of ₹182.26. GuruFocus considers Makers Laboratories to be Fairly Valued.

Key valuation signals for BOM:506919:

  • Cyclically Adjusted Revenue per Share: ₹198.92
  • GF Value™: ₹182.26 vs. price of ₹195.75 (7.4% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the BOM:506919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Makers Laboratories Business Description

Other Exchanges MAKERSL:India
Address 54-D, Kandivli Industrial Estate, Charkop, Kandivali (West), Mumbai, MH, IND, 400067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough Range), and Exylin (Amoxycillin range), among others. The reportable segment of the company is the Pharmaceutical segment.
67GF Score

Get the complete analysis for BOM:506919

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹195.75
Price
₹182.26
GF Value